Jeffrey E. Russel

Array ( [id] => 5889048 [patent_doc_number] => 20020013272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Novel cyclosporin galenic forms' [patent_app_type] => new [patent_app_number] => 09/931680 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14369 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013272.pdf [firstpage_image] =>[orig_patent_app_number] => 09931680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987898 [patent_doc_number] => 20020099175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Methods for the synthesis of a modified hemoglobin solution' [patent_app_type] => new [patent_app_number] => 09/930905 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10999 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099175.pdf [firstpage_image] =>[orig_patent_app_number] => 09930905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5338158 [patent_doc_number] => 20090054622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Peptide variants of the tumor marker MUC1 and their application' [patent_app_type] => utility [patent_app_number] => 09/931638 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1075 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054622.pdf [firstpage_image] =>[orig_patent_app_number] => 09931638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818214 [patent_doc_number] => 20030069172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Enhancing solubility of iron amino acid chelates and iron proteinates' [patent_app_type] => new [patent_app_number] => 09/931397 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4399 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069172.pdf [firstpage_image] =>[orig_patent_app_number] => 09931397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509132 [patent_doc_number] => 20020025919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Antiviral linear polymers' [patent_app_type] => new [patent_app_number] => 09/929014 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5185 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025919.pdf [firstpage_image] =>[orig_patent_app_number] => 09929014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7634709 [patent_doc_number] => 06656910 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-02 [patent_title] => 'Serine protease inhibitors' [patent_app_type] => B2 [patent_app_number] => 09/928117 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 33569 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/656/06656910.pdf [firstpage_image] =>[orig_patent_app_number] => 09928117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381718 [patent_doc_number] => 20020119985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Serine protease inhibitors' [patent_app_type] => new [patent_app_number] => 09/927832 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 34311 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119985.pdf [firstpage_image] =>[orig_patent_app_number] => 09927832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6654338 [patent_doc_number] => 20030077334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanism for normal and transformed cells' [patent_app_type] => new [patent_app_number] => 09/928243 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 38256 [patent_no_of_claims] => 137 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077334.pdf [firstpage_image] =>[orig_patent_app_number] => 09928243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7359180 [patent_doc_number] => 20040014189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Direct encapsulation of biomacromolecules in surfactant templated mesoporous and nanoporous materials' [patent_app_type] => new [patent_app_number] => 10/332423 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3440 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014189.pdf [firstpage_image] =>[orig_patent_app_number] => 10332423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529751 [patent_doc_number] => 20020136711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Compositions used in human treatment' [patent_app_type] => new [patent_app_number] => 09/919067 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11037 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20020136711.pdf [firstpage_image] =>[orig_patent_app_number] => 09919067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7616985 [patent_doc_number] => 06946456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-20 [patent_title] => 'Methods for treating cell proliferative disorders and viral infections' [patent_app_type] => utility [patent_app_number] => 10/343246 [patent_app_country] => US [patent_app_date] => 2001-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 10543 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946456.pdf [firstpage_image] =>[orig_patent_app_number] => 10343246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6934238 [patent_doc_number] => 20010055582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-27 [patent_title] => 'Erythropoietin solution preparation' [patent_app_type] => new [patent_app_number] => 09/909429 [patent_app_country] => US [patent_app_date] => 2001-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3289 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20010055582.pdf [firstpage_image] =>[orig_patent_app_number] => 09909429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000564 [patent_doc_number] => 20020028771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Antimicrobial sulfonamide derivatives of lipopeptide antibiotics' [patent_app_type] => new [patent_app_number] => 09/904756 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18117 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028771.pdf [firstpage_image] =>[orig_patent_app_number] => 09904756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343796 [patent_doc_number] => 20020035063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Derivatives of laspartomycin and preparation and use thereof' [patent_app_type] => new [patent_app_number] => 09/904352 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23165 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035063.pdf [firstpage_image] =>[orig_patent_app_number] => 09904352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 644706 [patent_doc_number] => 07118737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Polymer-modified synthetic proteins' [patent_app_type] => utility [patent_app_number] => 10/332385 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 62 [patent_no_of_words] => 58566 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/118/07118737.pdf [firstpage_image] =>[orig_patent_app_number] => 10332385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 741962 [patent_doc_number] => 07030218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Pseudo native chemical ligation' [patent_app_type] => utility [patent_app_number] => 10/332386 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26724 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030218.pdf [firstpage_image] =>[orig_patent_app_number] => 10332386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814068 [patent_doc_number] => 20030073618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof' [patent_app_type] => new [patent_app_number] => 09/903443 [patent_app_country] => US [patent_app_date] => 2001-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30380 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073618.pdf [firstpage_image] =>[orig_patent_app_number] => 09903443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1104516 [patent_doc_number] => 06811996 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-02 [patent_title] => 'DDS compounds and method for assaying the same' [patent_app_type] => B1 [patent_app_number] => 09/807980 [patent_app_country] => US [patent_app_date] => 2001-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 18378 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/811/06811996.pdf [firstpage_image] =>[orig_patent_app_number] => 09807980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473984 [patent_doc_number] => 20040097413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them' [patent_app_type] => new [patent_app_number] => 10/312341 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43415 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097413.pdf [firstpage_image] =>[orig_patent_app_number] => 10312341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849188 [patent_doc_number] => 07381706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same' [patent_app_type] => utility [patent_app_number] => 10/312637 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7524 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381706.pdf [firstpage_image] =>[orig_patent_app_number] => 10312637 [rel_patent_id] =>[rel_patent_doc_number] =>)